Key Points
The solid listing was fueled by multiple factors, including the company's strong market position as a one-stop solution provider for crop and soil health through its diverse branded product portfolio...
"Nova Agritech's consistent financial performance, impressive growth over the past three years, and ambitious expansion plans further bolstered investor sentiment..
For existing investors, holding their shares and closely monitoring the company's performance and market conditions remains the recommended approach," said Shivani Nyati, Head of Wealth at Swastika Investmart...
Nova AgriTech is an agri-input manufacturer offering soil health management, crop nutrition, and crop protection products focused on a tech-based farmer-driven solution approach, wherein it mainly offers ecologically sustainable and nutritionally balanced products based on R&D...
As of November 2023, it has received a total of 720 product registrations comprising 7 registrations in the soil health management category, 176 in the crop nutrition category, 4 in biopesticide category, 7 in technical indigenous manufacturing, and 526 in the crop protection category...
You might be interested in
Nova Agritech shares list at 37% premium over IPO price
31, Jan, 24Nova Agritech listed on exchanges with a 36.6% premium, debuting at Rs 56 on BSE and Rs 55 on NSE. The IPO received over 100 times subscription as non-institutional and institutional investors bid heavily. The company's solid financial track record and impressive ROE of 32.1% attracted analysts. Proceeds from the IPO will be used for subsidiary investment, capex, working capital, and investment in Nova Agri Sciences. Nova Agri Sciences contributes significantly to Nova Agritech's revenue by manufacturing crop protection products.
Economic growth to remain strong at 6.2% in 2024; private consumption and public spending to provide suppo
05, Jan, 24The UN projects India's economy to grow at 6.2% in 2024, citing robust domestic demand and sectoral growth. Despite a slight downward revision, the forecast underscores resilience, supported by government spending and supply chain diversification.
Go Digit IPO Day 3: Check latest subscription, GMP
19, May, 24Shares of the company are set to be listed on both BSE and NSE, with a tentative listing date of Thursday, May 23.
Zydus Lifesciences posts 53.3% jump in quarterly profit
07, Nov, 23India Business News: Indian pharmaceutical company Zydus Lifesciences reported a 53.3% increase in quarterly profit, driven by strong sales in the domestic and US markets.
Pyramid Technoplast among 5 IPOs to watch out for this week
13, Aug, 23Pyramid Technoplast aims to raise anywhere between Rs 139 crore - Rs 153 crore through the IPO, and the post implied market cap is likely to be around Rs 611 crore.
Nova Agritech IPO subscribed over 5x on Day 1: What should investors do? What analysts have to say
23, Jan, 24India Business News: Find out what investors should do and what analysts have to say about the Nova Agritech IPO. Get insights into the subscription numbers and expert recommendations.
Fedfina IPO: Fedbank Financial Services raises ₹329.99 crore in pre-IPO placement
21, Nov, 23Fedbank Financial Services IPO raised ₹329.99 crore through a pre-IPO placement of 23,571,428 equity shares at the upper end of the price band of ₹140 per equity share.
Jio Financial lists on D-St, falls 5% on expected passive fund selling
22, Aug, 23The shares which listed earlier than anticipated fell to ₹251.75 on the BSE, giving it a market value of ₹1.6 lakh crore, after opening trade at ₹265 apiece. The company, which has multiple lines of business in finance, was spun off from Reliance Industries.
Fedbank Financial Services IPO listing date today. Check what GMP, experts signal on share debut
30, Nov, 23Fedbank Financial Services IPO GMP today: Shares of the NBFC are not available for trade in grey market today, say market observers
Blue Jet Healthcare IPO subscribed nearly 8 times at close. Check GMP and other details
27, Oct, 23According to market analysts, Blue Jet Healthcare's shares are fetching a premium of Rs 22 in the unlisted market. Most analysts have a 'subscribe' recommendation on the IPO, which is entirely an offer for sale of 2.42 crore shares.